|
chr4_+_74488947
|
4.280
|
|
ALB
|
albumin
|
|
chr4_+_74488910
|
3.984
|
|
ALB
|
albumin
|
|
chr4_+_74488835
|
3.632
|
NM_000477
|
ALB
|
albumin
|
|
chr11_+_12652427
|
3.450
|
NM_021961
|
TEAD1
|
TEA domain family member 1 (SV40 transcriptional enhancer factor)
|
|
chr10_-_95350949
|
2.383
|
NM_006744
|
RBP4
|
retinol binding protein 4, plasma
|
|
chr2_-_224611568
|
2.347
|
NM_001136530
|
SERPINE2
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2
|
|
chr2_-_216009015
|
2.196
|
NM_002026
NM_054034
NM_212474
NM_212476
NM_212478
NM_212482
|
FN1
|
fibronectin 1
|
|
chr20_+_19863716
|
1.746
|
|
RIN2
|
Ras and Rab interactor 2
|
|
chr4_+_100704262
|
1.667
|
NM_000253
|
MTTP
|
microsomal triglyceride transfer protein
|
|
chr3_+_189354167
|
1.640
|
NM_001167672
|
LPP
|
LIM domain containing preferred translocation partner in lipoma
|
|
chr17_+_50697355
|
1.563
|
|
HLF
|
hepatic leukemia factor
|
|
chr4_+_75529716
|
1.487
|
NM_001657
|
AREG
|
amphiregulin
|
|
chr4_+_75699652
|
1.444
|
NM_001657
|
AREG
|
amphiregulin
|
|
chr16_-_4528739
|
1.426
|
NM_001199055
NM_001199056
NM_013399
|
C16orf5
|
chromosome 16 open reading frame 5
|
|
chr21_-_42060266
|
1.413
|
NM_020639
|
RIPK4
|
receptor-interacting serine-threonine kinase 4
|
|
chr21_-_42060334
|
1.383
|
|
RIPK4
|
receptor-interacting serine-threonine kinase 4
|
|
chr17_+_50697319
|
1.357
|
NM_002126
|
HLF
|
hepatic leukemia factor
|
|
chrX_-_13745108
|
1.356
|
|
GPM6B
|
glycoprotein M6B
|
|
chr11_+_116575249
|
1.353
|
NM_001001522
NM_003186
|
TAGLN
|
transgelin
|
|
chr6_-_47385605
|
1.344
|
NM_014452
|
TNFRSF21
|
tumor necrosis factor receptor superfamily, member 21
|
|
chr10_+_4995597
|
1.308
|
|
AKR1C1
AKR1C3
|
aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)
aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II)
|
|
chr3_-_101077605
|
1.298
|
NM_014890
|
FILIP1L
|
filamin A interacting protein 1-like
|
|
chr21_-_26175068
|
1.295
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
chrX_-_13744933
|
1.279
|
|
GPM6B
|
glycoprotein M6B
|
|
chr2_-_220116508
|
1.236
|
NM_024536
|
CHPF
|
chondroitin polymerizing factor
|
|
chrX_-_128485134
|
1.233
|
NM_003069
NM_139035
|
SMARCA1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1
|
|
chr6_-_47385470
|
1.232
|
|
TNFRSF21
|
tumor necrosis factor receptor superfamily, member 21
|
|
chrX_-_128485121
|
1.212
|
|
SMARCA1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1
|
|
chr10_-_5035967
|
1.206
|
NM_001135241
|
AKR1C1
AKR1C2
|
aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)
aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase 2; bile acid binding protein; 3-alpha hydroxysteroid dehydrogenase, type III)
|
|
chr10_-_99436889
|
1.174
|
NM_021732
|
AVPI1
|
arginine vasopressin-induced 1
|
|
chr20_-_14266200
|
1.165
|
NM_013281
NM_198391
|
FLRT3
|
fibronectin leucine rich transmembrane protein 3
|
|
chr12_+_12935619
|
1.143
|
|
GPRC5A
|
G protein-coupled receptor, family C, group 5, member A
|
|
chr10_+_4995453
|
1.138
|
NM_001353
|
AKR1C1
|
aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)
|
|
chr20_+_55569542
|
1.104
|
NM_002591
|
PCK1
|
phosphoenolpyruvate carboxykinase 1 (soluble)
|
|
chr4_+_85723080
|
1.100
|
NM_001263
|
CDS1
|
CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1
|
|
chr2_-_216008689
|
1.099
|
|
FN1
|
fibronectin 1
|
|
chr16_-_54424473
|
1.072
|
|
CES1
|
carboxylesterase 1
|
|
chr1_-_16355013
|
1.069
|
NM_004431
|
EPHA2
|
EPH receptor A2
|
|
chr17_+_38306339
|
1.040
|
NM_000151
|
G6PC
|
glucose-6-phosphatase, catalytic subunit
|
|
chr9_+_102987137
|
1.035
|
NM_017753
|
LPPR1
|
lipid phosphate phosphatase-related protein type 1
|
|
chr20_+_4614796
|
1.031
|
NM_000311
NM_001080121
NM_001080122
NM_183079
NM_001080123
|
PRNP
|
prion protein
|
|
chr8_+_26569709
|
1.027
|
|
DPYSL2
|
dihydropyrimidinase-like 2
|
|
chr10_+_4995685
|
1.026
|
|
AKR1C1
|
aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)
|
|
chr6_-_47385313
|
1.015
|
|
TNFRSF21
|
tumor necrosis factor receptor superfamily, member 21
|
|
chr13_+_47705493
|
0.998
|
|
ITM2B
|
integral membrane protein 2B
|
|
chr7_+_129918408
|
0.998
|
NM_177525
|
MEST
|
mesoderm specific transcript homolog (mouse)
|
|
chr12_-_90029328
|
0.997
|
|
LUM
|
lumican
|
|
chr16_-_54424517
|
0.989
|
NM_001025194
NM_001025195
NM_001266
|
CES1
|
carboxylesterase 1
|
|
chr1_-_1283770
|
0.985
|
NM_032348
|
MXRA8
|
matrix-remodelling associated 8
|
|
chr11_-_8849485
|
0.956
|
|
ST5
|
suppression of tumorigenicity 5
|
|
chrX_-_13745234
|
0.955
|
NM_001001995
NM_001001996
NM_005278
|
GPM6B
|
glycoprotein M6B
|
|
chr3_-_188946168
|
0.953
|
NM_001706
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
chr19_-_62043867
|
0.944
|
NM_001146326
NM_001146327
NM_015363
NM_001146184
NM_001146185
NM_001146187
NM_006210
|
ZIM2
PEG3
|
zinc finger, imprinted 2
paternally expressed 3
|
|
chr2_-_237987509
|
0.934
|
|
COL6A3
|
collagen, type VI, alpha 3
|
|
chr9_+_96528764
|
0.930
|
NM_001193331
NM_032823
|
C9orf3
|
chromosome 9 open reading frame 3
|
|
chr2_-_237987579
|
0.929
|
NM_004369
NM_057164
NM_057165
NM_057166
NM_057167
|
COL6A3
|
collagen, type VI, alpha 3
|
|
chr9_+_96528814
|
0.924
|
|
C9orf3
|
chromosome 9 open reading frame 3
|
|
chr1_+_154297588
|
0.910
|
NM_020387
|
RAB25
|
RAB25, member RAS oncogene family
|
|
chr11_-_66482366
|
0.910
|
NM_000920
NM_001040716
|
PC
|
pyruvate carboxylase
|
|
chr6_-_47385205
|
0.905
|
|
TNFRSF21
|
tumor necrosis factor receptor superfamily, member 21
|
|
chr10_+_123913094
|
0.902
|
NM_006997
NM_206860
|
TACC2
|
transforming, acidic coiled-coil containing protein 2
|
|
chr17_+_64020155
|
0.886
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1)
|
|
chrX_-_10605726
|
0.879
|
NM_001098624
|
MID1
|
midline 1 (Opitz/BBB syndrome)
|
|
chr16_-_78192111
|
0.875
|
NM_001031804
NM_005360
|
MAF
|
v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian)
|
|
chr15_-_61461127
|
0.871
|
NM_001218
NM_206925
|
CA12
|
carbonic anhydrase XII
|
|
chr20_-_17897384
|
0.866
|
NM_152227
|
SNX5
|
sorting nexin 5
|
|
chr8_+_98857190
|
0.858
|
|
LAPTM4B
|
lysosomal protein transmembrane 4 beta
|
|
chr5_+_150380173
|
0.855
|
NM_002084
|
GPX3
|
glutathione peroxidase 3 (plasma)
|
|
chrX_-_13866565
|
0.850
|
NM_001001994
|
GPM6B
|
glycoprotein M6B
|
|
chr5_-_95323353
|
0.848
|
NM_012081
|
ELL2
|
elongation factor, RNA polymerase II, 2
|
|
chr13_-_43908937
|
0.848
|
|
TSC22D1
|
TSC22 domain family, member 1
|
|
chr15_-_61460967
|
0.831
|
|
CA12
|
carbonic anhydrase XII
|
|
chr12_-_90029672
|
0.827
|
NM_002345
|
LUM
|
lumican
|
|
chr2_-_237987554
|
0.816
|
|
COL6A3
|
collagen, type VI, alpha 3
|
|
chr16_-_10581944
|
0.809
|
NM_001424
|
EMP2
|
epithelial membrane protein 2
|
|
chr5_-_172130766
|
0.800
|
NM_004417
|
DUSP1
|
dual specificity phosphatase 1
|
|
chr8_+_26296439
|
0.784
|
NM_004331
|
BNIP3L
|
BCL2/adenovirus E1B 19kDa interacting protein 3-like
|
|
chrX_-_128485062
|
0.781
|
|
SMARCA1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1
|
|
chr14_-_93919305
|
0.750
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
chr5_+_150380270
|
0.737
|
|
GPX3
|
glutathione peroxidase 3 (plasma)
|
|
chr22_+_36927884
|
0.737
|
NM_001161572
NM_001161574
NM_012323
|
MAFF
|
v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian)
|
|
chr12_+_12935759
|
0.724
|
|
GPRC5A
|
G protein-coupled receptor, family C, group 5, member A
|
|
chr10_-_52315436
|
0.721
|
NM_001198818
NM_001198819
NM_001198820
NM_014576
NM_138932
NM_138933
|
A1CF
|
APOBEC1 complementation factor
|
|
chr19_+_50041400
|
0.698
|
|
PVRL2
|
poliovirus receptor-related 2 (herpesvirus entry mediator B)
|
|
chr21_-_43671355
|
0.690
|
NM_173354
|
SIK1
|
salt-inducible kinase 1
|
|
chr21_+_46369617
|
0.689
|
|
COL6A2
|
collagen, type VI, alpha 2
|
|
chr19_-_56919032
|
0.686
|
NM_001523
|
HAS1
|
hyaluronan synthase 1
|
|
chr1_+_99502655
|
0.684
|
|
LPPR4
|
lipid phosphate phosphatase-related protein type 4
|
|
chr4_-_156517394
|
0.684
|
|
MAP9
|
microtubule-associated protein 9
|
|
chr3_+_8518508
|
0.681
|
NM_014583
|
LMCD1
|
LIM and cysteine-rich domains 1
|
|
chr9_-_128924819
|
0.672
|
NM_012098
|
ANGPTL2
|
angiopoietin-like 2
|
|
chr4_-_23500706
|
0.670
|
NM_013261
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
chr3_-_187309442
|
0.663
|
NM_004454
|
ETV5
|
ets variant 5
|
|
chr1_-_1274618
|
0.651
|
|
DVL1
|
dishevelled, dsh homolog 1 (Drosophila)
|
|
chr21_-_35343500
|
0.643
|
|
RUNX1
|
runt-related transcription factor 1
|
|
chr4_-_156517423
|
0.641
|
|
MAP9
|
microtubule-associated protein 9
|
|
chr10_+_124141808
|
0.641
|
NM_021622
|
PLEKHA1
|
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1
|
|
chr1_+_29435534
|
0.633
|
NM_001195001
NM_005704
NM_133177
NM_133178
|
PTPRU
|
protein tyrosine phosphatase, receptor type, U
|
|
chrX_+_107569671
|
0.624
|
NM_000495
NM_033380
|
COL4A5
|
collagen, type IV, alpha 5
|
|
chr1_+_1994943
|
0.620
|
NM_001033581
|
PRKCZ
|
protein kinase C, zeta
|
|
chr16_+_70646008
|
0.620
|
NM_001126102
NM_005143
|
HP
|
haptoglobin
|
|
chr6_+_148705421
|
0.615
|
NM_015278
|
SASH1
|
SAM and SH3 domain containing 1
|
|
chr21_-_35343456
|
0.611
|
NM_001754
|
RUNX1
|
runt-related transcription factor 1
|
|
chr14_+_67156386
|
0.597
|
|
ARG2
|
arginase, type II
|
|
chr1_-_59022275
|
0.594
|
NM_002228
|
JUN
|
jun proto-oncogene
|
|
chr17_+_69939806
|
0.589
|
|
GPRC5C
|
G protein-coupled receptor, family C, group 5, member C
|
|
chr4_+_155707089
|
0.586
|
|
FGB
|
fibrinogen beta chain
|
|
chr7_-_41709191
|
0.584
|
NM_002192
|
INHBA
|
inhibin, beta A
|
|
chr14_+_23633101
|
0.581
|
NM_001018073
NM_004563
|
PCK2
|
phosphoenolpyruvate carboxykinase 2 (mitochondrial)
|
|
chrX_-_13866451
|
0.581
|
|
GPM6B
|
glycoprotein M6B
|
|
chrX_+_43399101
|
0.579
|
|
MAOA
|
monoamine oxidase A
|
|
chr19_+_50663089
|
0.576
|
NM_001114171
NM_006732
|
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B
|
|
chr4_-_156517544
|
0.576
|
NM_001039580
|
MAP9
|
microtubule-associated protein 9
|
|
chr6_+_39868126
|
0.575
|
|
DAAM2
|
dishevelled associated activator of morphogenesis 2
|
|
chrX_-_13745134
|
0.565
|
|
GPM6B
|
glycoprotein M6B
|
|
chr8_-_42184350
|
0.562
|
NM_000930
NM_033011
|
PLAT
|
plasminogen activator, tissue
|
|
chr8_-_42184194
|
0.562
|
|
PLAT
|
plasminogen activator, tissue
|
|
chr11_-_8788765
|
0.556
|
NM_213618
|
ST5
|
suppression of tumorigenicity 5
|
|
chr2_+_148319033
|
0.551
|
NM_001616
|
ACVR2A
|
activin A receptor, type IIA
|
|
chr3_+_62279707
|
0.549
|
|
C3orf14
|
chromosome 3 open reading frame 14
|
|
chr17_-_38978772
|
0.549
|
NM_001986
|
ETV4
|
ets variant 4
|
|
chr19_+_50041387
|
0.544
|
|
PVRL2
|
poliovirus receptor-related 2 (herpesvirus entry mediator B)
|
|
chr14_+_67156323
|
0.543
|
NM_001172
|
ARG2
|
arginase, type II
|
|
chr17_+_38831874
|
0.542
|
NM_001661
|
ARL4D
|
ADP-ribosylation factor-like 4D
|
|
chr14_+_67156405
|
0.542
|
|
ARG2
|
arginase, type II
|
|
chr7_+_73506047
|
0.538
|
NM_016328
|
GTF2IRD1
|
GTF2I repeat domain containing 1
|
|
chr17_-_38979178
|
0.536
|
NM_001079675
|
ETV4
|
ets variant 4
|
|
chr17_+_77783432
|
0.533
|
NM_001042423
|
SLC16A3
|
solute carrier family 16, member 3 (monocarboxylic acid transporter 4)
|
|
chr3_-_188945921
|
0.529
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
chr12_-_100979923
|
0.526
|
NM_016053
|
CCDC53
|
coiled-coil domain containing 53
|
|
chr2_-_73170290
|
0.524
|
|
RAB11FIP5
|
RAB11 family interacting protein 5 (class I)
|
|
chr9_-_128924706
|
0.521
|
|
ANGPTL2
|
angiopoietin-like 2
|
|
chr22_+_36928011
|
0.509
|
|
MAFF
|
v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian)
|
|
chr5_+_36642213
|
0.493
|
NM_001166696
NM_004172
|
SLC1A3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 3
|
|
chr3_+_160473729
|
0.491
|
NM_001197107
NM_001197108
NM_014575
|
SCHIP1
|
schwannomin interacting protein 1
|
|
chr9_+_96561750
|
0.491
|
NM_001193329
|
C9orf3
|
chromosome 9 open reading frame 3
|
|
chr4_-_186693574
|
0.490
|
NM_001114107
NM_014476
|
PDLIM3
|
PDZ and LIM domain 3
|
|
chr16_+_70654625
|
0.486
|
NM_020995
|
HPR
|
haptoglobin-related protein
|
|
chr1_-_20682541
|
0.485
|
|
|
|
|
chr14_+_95740768
|
0.479
|
NM_000623
|
BDKRB2
|
bradykinin receptor B2
|
|
chr2_+_101874765
|
0.475
|
|
MAP4K4
|
mitogen-activated protein kinase kinase kinase kinase 4
|
|
chr5_-_95323180
|
0.475
|
|
ELL2
|
elongation factor, RNA polymerase II, 2
|
|
chr17_+_64020159
|
0.475
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1)
|
|
chr17_-_77824849
|
0.474
|
NM_001893
NM_139062
|
CSNK1D
|
casein kinase 1, delta
|
|
chr1_+_227506751
|
0.461
|
NM_006542
|
SPHAR
|
S-phase response (cyclin related)
|
|
chr16_-_4528380
|
0.460
|
NM_001199054
|
C16orf5
|
chromosome 16 open reading frame 5
|
|
chr11_-_35397675
|
0.457
|
NM_004171
|
SLC1A2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2
|
|
chr11_+_61204392
|
0.455
|
NM_006133
|
DAGLA
|
diacylglycerol lipase, alpha
|
|
chr6_+_89848229
|
0.450
|
|
PNRC1
|
proline-rich nuclear receptor coactivator 1
|
|
chr3_-_101316038
|
0.449
|
NM_001042459
NM_182909
|
FILIP1L
|
filamin A interacting protein 1-like
|
|
chr3_+_134976965
|
0.443
|
|
TF
|
transferrin
|
|
chr3_+_23962518
|
0.442
|
NM_001145425
|
NR1D2
|
nuclear receptor subfamily 1, group D, member 2
|
|
chr6_+_32021687
|
0.442
|
NM_001710
|
CFB
|
complement factor B
|
|
chr14_-_68424653
|
0.442
|
|
ACTN1
|
actinin, alpha 1
|
|
chr5_+_34723420
|
0.442
|
NM_001145523
|
RAI14
|
retinoic acid induced 14
|
|
chr5_+_36642424
|
0.436
|
|
SLC1A3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 3
|
|
chr1_+_65385799
|
0.435
|
NM_203464
NM_001005353
|
AK4
|
adenylate kinase 4
|
|
chr5_+_150380325
|
0.435
|
|
GPX3
|
glutathione peroxidase 3 (plasma)
|
|
chr6_-_47385599
|
0.434
|
|
TNFRSF21
|
tumor necrosis factor receptor superfamily, member 21
|
|
chr11_-_2118916
|
0.427
|
NM_001127598
|
IGF2
|
insulin-like growth factor 2 (somatomedin A)
|
|
chr17_+_35148084
|
0.427
|
NM_001030002
|
GRB7
|
growth factor receptor-bound protein 7
|
|
chr1_+_181380837
|
0.422
|
|
LAMC1
|
laminin, gamma 1 (formerly LAMB2)
|
|
chr2_-_188127430
|
0.417
|
NM_001032281
NM_006287
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
chr14_-_35348086
|
0.415
|
NM_014990
NM_194301
|
RALGAPA1
|
Ral GTPase activating protein, alpha subunit 1 (catalytic)
|
|
chr8_-_145097031
|
0.410
|
NM_201380
|
PLEC
|
plectin
|
|
chr8_+_40130143
|
0.410
|
NM_020130
|
C8orf4
|
chromosome 8 open reading frame 4
|
|
chrX_-_131375217
|
0.407
|
NM_001170701
NM_001170702
NM_001170703
|
MBNL3
|
muscleblind-like 3 (Drosophila)
|
|
chr8_+_132985521
|
0.402
|
NM_015137
|
EFR3A
|
EFR3 homolog A (S. cerevisiae)
|
|
chr9_-_32542550
|
0.402
|
|
TOPORS
|
topoisomerase I binding, arginine/serine-rich, E3 ubiquitin protein ligase
|
|
chr12_+_70120028
|
0.401
|
NM_003667
|
LGR5
|
leucine-rich repeat containing G protein-coupled receptor 5
|
|
chr2_+_54638957
|
0.400
|
NM_178313
|
SPTBN1
|
spectrin, beta, non-erythrocytic 1
|
|
chr2_+_5750229
|
0.398
|
NM_003108
|
SOX11
|
SRY (sex determining region Y)-box 11
|
|
chr5_-_121441910
|
0.398
|
NM_002317
|
LOX
|
lysyl oxidase
|
|
chr5_-_121441866
|
0.396
|
|
LOX
|
lysyl oxidase
|
|
chr14_-_68329407
|
0.391
|
NM_004926
|
ZFP36L1
|
zinc finger protein 36, C3H type-like 1
|
|
chr6_+_148705646
|
0.391
|
|
SASH1
|
SAM and SH3 domain containing 1
|
|
chr4_-_111777651
|
0.389
|
|
PITX2
|
paired-like homeodomain 2
|
|
chr3_+_8518539
|
0.387
|
|
LMCD1
|
LIM and cysteine-rich domains 1
|
|
chr4_-_111777584
|
0.387
|
|
PITX2
|
paired-like homeodomain 2
|
|
chr2_+_101874809
|
0.379
|
|
MAP4K4
|
mitogen-activated protein kinase kinase kinase kinase 4
|
|
chr9_-_32542573
|
0.378
|
NM_001195622
NM_005802
|
TOPORS
|
topoisomerase I binding, arginine/serine-rich, E3 ubiquitin protein ligase
|
|
chr5_-_133734616
|
0.376
|
|
CDKL3
|
cyclin-dependent kinase-like 3
|
|
chr20_-_17897067
|
0.367
|
NM_014426
|
SNX5
|
sorting nexin 5
|
|
chr6_-_46566969
|
0.366
|
|
RCAN2
|
regulator of calcineurin 2
|
|
chr9_-_128924782
|
0.365
|
|
ANGPTL2
|
angiopoietin-like 2
|
|
chr1_+_110328850
|
0.365
|
|
AHCYL1
|
adenosylhomocysteinase-like 1
|
|
chr3_-_78749633
|
0.363
|
|
ROBO1
|
roundabout, axon guidance receptor, homolog 1 (Drosophila)
|
|
chr17_-_75385371
|
0.362
|
NM_020649
|
CBX8
|
chromobox homolog 8
|
|
chr12_+_70119785
|
0.361
|
|
LGR5
|
leucine-rich repeat containing G protein-coupled receptor 5
|
|
chr5_+_32747194
|
0.359
|
NM_000908
|
NPR3
|
natriuretic peptide receptor C/guanylate cyclase C (atrionatriuretic peptide receptor C)
|
|
chrX_-_10495476
|
0.355
|
NM_001193278
NM_001193279
NM_001193280
NM_001193281
|
MID1
|
midline 1 (Opitz/BBB syndrome)
|
|
chr17_+_71033339
|
0.354
|
NM_001015002
NM_001031803
NM_004524
|
LLGL2
|
lethal giant larvae homolog 2 (Drosophila)
|
|
chr8_-_95343696
|
0.354
|
|
GEM
|
GTP binding protein overexpressed in skeletal muscle
|
|
chr20_+_43236953
|
0.349
|
NM_002638
|
PI3
|
peptidase inhibitor 3, skin-derived
|
|
chr3_-_126257425
|
0.349
|
NM_020733
|
HEG1
|
HEG homolog 1 (zebrafish)
|
|
chr8_-_49996353
|
0.349
|
NM_003068
|
SNAI2
|
snail homolog 2 (Drosophila)
|
|
chr16_+_415606
|
0.348
|
|
RAB11FIP3
|
RAB11 family interacting protein 3 (class II)
|
|
chr3_-_55496370
|
0.346
|
NM_003392
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
chr10_-_73953699
|
0.346
|
NM_001195519
|
CBARA1
|
calcium binding atopy-related autoantigen 1
|
|
chr5_-_78318112
|
0.345
|
NM_000046
|
ARSB
|
arylsulfatase B
|
